Xspray Pharma AB (publ) (STO: XSPRAY)

Sweden flag Sweden · Delayed Price · Currency is SEK
51.70
+0.40 (0.78%)
Aug 30, 2024, 5:29 PM CET
61.56%
Market Cap 1.75B
Revenue n/a
Net Income -214.76M
Shares Out 33.76M
EPS -6.88
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,293
Open 51.40
Previous Close 51.30
Day's Range 50.40 - 51.80
52-Week Range 30.90 - 91.70
Beta 0.92
Analysts n/a
Price Target n/a
Earnings Date Nov 6, 2024

About Xspray Pharma AB

Xspray Pharma AB (publ), a pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden. The company’s product candidates include Dasynoc, a trailblazer, under approval phase for the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia; XS003, an amorphous non-crystalline nilotinib, under pivotal studies for the treatment of chronic myeloid leukemia; XS008, based on axitinib, under development for treatment of kidney cancer; and XS00Y under development phase. It has p... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2003
Employees 26
Stock Exchange Nasdaq Stockholm
Ticker Symbol XSPRAY
Full Company Profile

News

There is no news available yet.